跳至主要内容
临床试验/CTRI/2026/03/106989
CTRI/2026/03/106989尚未招募不适用

Role of Anti-Mullerian hormone (AMH) levels in predicting ovulatory response among PCOS women undergoing ovulation induction with letrozole – A Prospective cohort study.

Intramural Research Fund Committee JIPMER1 个研究点 分布在 1 个国家目标入组 167 人开始时间: 2026年4月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
167
试验地点
1

研究概览

简要总结

This is a prospective cohort study titled Role of Anti-Mullerian hormone levels in predicting ovulatory response among PCOS women undergoing ovulation induction with letrozole. we conduct this study on women diagnosed with PCOS based on Rotterdam criteria aged 21-40 years seeking fertility treatment in WCH, JIPMER. Baseline infertility investigations including serum AMH levels done followed by ovulation induction with tablet LETROZOLE and assess ovulatory response. the primary objective is To assess the predictive accuracy of Serum AMH level on detecting Ovulatory response among PCOS women undergoing ovulation induction with letrozole. The secondary objective is To correlate the dose of Letrozole lor ovulation induction with Serum AMH level.

研究设计

研究类型
Observational

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • women diagnosed with PCOS by Rotterdam criteria aged 21-40 years.

排除标准

  • Women with functional ovarian cyst
  • Associated endometriotic cyst
  • Women on Oral contraceptive pills within 3 months
  • Women with history of Ovarian surgery
  • Chemotherapy/ Radiotherapy.

研究者

发起方
Intramural Research Fund Committee JIPMER
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Madhivani Subburayalu

Jawaharlal Institute of Postgraduate Medical Education and Research Puducherry.

研究点 (1)

Loading locations...

相似试验